131 results
Patients are reporting lingering symptoms after acute COVID-19. Read about post-acute COVID-19 syndrome (PACS) also known as long COVID.
What’s on the horizon beyond infection prevention and supportive care for COVID-19? Read about some of the drugs in clinical trials.
In April 2020, the DynaMed® EBM Focus team answered ten common clinical questions about COVID-19. Here is an updated list of questions physicians are asking now.
Patients visiting their physicians are asking a lot of questions about COVID-19. Here are answers to ten most commonly asked questions from the Infectious Diseases team at DynaMed®.
Molnupiravir is a new antiviral pill to treat COVID-19. Here’s what we know so far.
EBSCO Chief Medical Knowledge Officer and DynaMed® Founder Dr. Brian Alper launches an innovative effort to uncover scientific knowledge related to COVID-19.
COVID-19 represents the most recent example of health disparity among Black patients in America. This EBM Focus article discusses a study evaluating this inequity.
Patients with pre-existing conditions are at a higher risk for severe COVID-19. Read about considerations for certain high-risk patient populations during the pandemic.
With the start of the school year around the corner, risk of COVID-19 is a top concern for parents, teachers, school administrators and pediatricians. Here’s a roundup of what we know about COVID-19 vaccines for children and adolescents.
A new project from EBSCO is helping clinicians bridge the evidence gap between trial data reporting and publication of peer-reviewed articles during the COVID-19 pandemic.